Company profile
Sagimet Biosciences Inc.
SGMT · NASDAQ (SEC company_tickers_exchange.json lists Sagimet Biosciences Inc. (CIK 0001400118) as Nasdaq: SGMT; reconciled during the MASH/NASH v2 entity pass.) · USA
Share price · SGMT
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Unadjusted for historical splits · Data via Databento
Assets
(1 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Fatty acid synthase (FASN) · FASNSmall molecule | MASH / NASH |
Upcoming events
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.
Insider transactions
Unlock insider transactions
Research includes SEC Form 4 insider transactions — filed buys, sells, awards and exercises linked to the underlying filings.
Institutional holders
Unlock institutional holders
Research includes quarterly SEC 13F institutional ownership — top holders, aggregate positions and quarter-over-quarter context.